Kuchepetsa thupi Semaglutide CAS 910463-68-2
Kufotokozera
Semaglutide(910463-68-2) ndi mankhwala oletsa shuga omwe amagulitsidwa pansi pa mayina monga Ozempic, Wegovy, ndi Rybelsus.Amagwiritsidwa ntchito pochiza matenda amtundu wa 2 ndikuwongolera kulemera kosatha.Mankhwalawa amagwira ntchito mofanana ndi glucagon-like peptide-1 (GLP-1) powonjezera katulutsidwe ka insulini, zomwe zimapangitsa kuti shuga aziyenda bwino.Imagawidwa ngati jekeseni wa metered subcutaneous mu cholembera chodzaza kale, kapena ngati mawonekedwe amkamwa.Chimodzi mwazabwino zake kuposa mankhwala ena a antidiabetic ndikuti amakhala ndi nthawi yayitali yochitapo kanthu, motero, jekeseni kamodzi kokha pa sabata ndikwanira.
Ntchito
Semaglutide imagwiritsidwa ntchito poyang'anira matenda a shuga a 2 pamodzi ndi kusintha kwa moyo, monga zoletsa zakudya komanso kuchita masewera olimbitsa thupi.Zimagwiranso ntchito pochepetsa kuyenda kwa chakudya m'mimba ndipo zimatha kuchepetsa chilakolako cha chakudya ndikuchepetsa thupi.Sipanakhalepo malipoti osindikizidwa a hepatotoxicity otchedwa semaglutide therapy.
Njira yochitira
Semaglutide ndi glucagon-ngati peptide-1 receptor agonist.Imawonjezera kupanga kwa insulin, mahomoni omwe amachepetsa shuga m'magazi.Zikuwonekeranso kuti zimathandizira kukula kwa ma cell a β mu kapamba, omwe ndi malo omwe amapanga insulin.Imalepheretsanso glucagon, mahomoni omwe amawonjezera shuga m'magazi.Komanso amachepetsa kudya ndi kuchepetsa chilakolako ndi kuchepetsa chimbudzi m'mimba.Mwanjira imeneyi amachepetsa mafuta a thupi.
Ntchito Zachilengedwe
Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), glucagon-ngati peptide 1 (GLP-1) analogue, ndi GLP-1 receptor agonist yemwe angathe kuchiza matenda a shuga a mtundu wa 2. (T2DM).
Kupaka & Kutumiza
